Filtered By:
Specialty: Pharmaceuticals
This page shows you your search results in order of date. This is page number 5.
Order by Relevance | Date
Total 890 results found since Jan 2013.
Sleep Problems Linked to Increased Risk for Stroke
THURSDAY, April 6, 2023 -- Sleep problems are associated with an increased risk for stroke, according to a study published online April 5 in Neurology.
Christine Eileen McCarthy, M.B., B.Ch., from the National University of Ireland in Galway, and...
Source: Drugs.com - Pharma News - April 6, 2023 Category: Pharmaceuticals Source Type: news
ERLEADA ® (apalutamide), First-and-Only Next-Generation Androgen Receptor Inhibitor with Once-Daily, Single-Tablet Option, Now Available in the U.S.
HORSHAM, Pa., April 3, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the availability of an additional tablet strength of ERLEADA® (apalutamide) in the United States. The introduction of the 240mg tablet provides the first-and-only option for a once-daily, single-tablet Androgen Receptor Inhibitor (ARI) approved for the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC) and for the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC).With two strengths available, healthcare professionals will have the flexibility to...
Source: Johnson and Johnson - April 3, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Cell Therapy Prevents Risk Of Heart Attack or Stroke: Study
A recent study searches for a permanent solution to repair the heart via stem cell therapy.
Source: Forbes.com Healthcare News - March 24, 2023 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news
Depressive Symptoms Linked to Risk for Acute Stroke
WEDNESDAY, March 8, 2023 -- Depressive symptoms are associated with an increased risk for acute stroke, according to a study published online March 8 in Neurology.
Robert P. Murphy, M.B.B.S., from the HRB Clinical Research Facility Galway in...
Source: Drugs.com - Pharma News - March 8, 2023 Category: Pharmaceuticals Source Type: news
Mechanical Thrombectomy Comparable to Best Medical Treatment for Rare Type of Stroke
TUESDAY, March 7, 2023 -- For patients with primary isolated distal medium vessel occlusions (DMVOs) of the anterior cerebral artery (ACA), mechanical thrombectomy (MT) has comparable clinical and safety outcomes to best medical treatment (BMT),...
Source: Drugs.com - Pharma News - March 7, 2023 Category: Pharmaceuticals Source Type: news
New VOYAGER PAD Analysis Confirms Consistent Benefit of XARELTO ® (rivaroxaban) Plus Aspirin Following Lower Extremity Revascularization (LER)
TITUSVILLE, NJ, March 5, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from a new prespecified analysis from the Phase 3 VOYAGER PAD clinical trial reinforcing the benefits of the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) over standard of care (aspirin alone), demonstrating consistent benefit at 30 days, 90 days and up to three years following LER in patients with PAD. Lower extremity revascularization, also called peripheral revascularization, is a procedure that restores blood flow in blocked arteries or veins. This analysis of ...
Source: Johnson and Johnson - March 5, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
One in Three U.S. Adults Do Not Receive Rehabilitation Therapy After Stroke
FRIDAY, Feb. 24, 2023 -- Use of rehabilitative therapy during the first year poststroke is low in the United States, according to a study published online Feb. 3 in Stroke.
Brittany M. Young, M.D., Ph.D., from the University of California in Los...
Source: Drugs.com - Pharma News - February 24, 2023 Category: Pharmaceuticals Source Type: news
Hypertensive Disorders of Pregnancy Linked to Risk for CVD
FRIDAY, Feb. 24, 2023 -- Genetic evidence indicates that hypertensive disorders of pregnancy (HDPs) are associated with an increased risk for atherosclerotic cardiovascular disease, specifically coronary artery disease and ischemic stroke, according...
Source: Drugs.com - Pharma News - February 24, 2023 Category: Pharmaceuticals Source Type: news
Pioglitazone Use Linked to Reduced Dementia Risk in T2DM
THURSDAY, Feb. 16, 2023 -- For patients with diabetes mellitus (DM), pioglitazone use is associated with a reduced risk for dementia, especially in those with a history of ischemic heart disease or stroke, according to a study published online Feb....
Source: Drugs.com - Pharma News - February 16, 2023 Category: Pharmaceuticals Source Type: news
Janssen Data at ASCO GU Support Ambition to Transform Treatment of Prostate and Bladder Cancer Through Precision Medicine and Early Intervention
RARITAN, N.J., February 13, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced plans to present more than 20 abstracts featuring seven oncology therapies from its robust portfolio and pipeline at the annual American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium, taking place in San Francisco on February 16-18. Building on more than a decade of leadership in the development of medicines for people diagnosed with GU cancers, Janssen will present data demonstrating its ambition to advance patient-centered treatment through precision medicine, real-world evidence a...
Source: Johnson and Johnson - February 13, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
ASA: Stem Cell Transplant Improves Vasculopathy in Sickle Cell Patients
THURSDAY, Feb. 9, 2023 -- For adults with sickle cell disease (SCD), hematopoietic stem cell transplantation (HSCT) seems to improve or prevent development of vasculopathies, according to a study presented at the American Stroke Association...
Source: Drugs.com - Pharma News - February 9, 2023 Category: Pharmaceuticals Source Type: news
ASA: Sex Differences Seen in Use of Dual Antiplatelet Therapy After Minor Stroke
THURSDAY, Feb. 9, 2023 -- Dual antiplatelet therapy (DAPT) is underused following transient ischemic attack (TIA) and minor acute ischemic stroke (AIS), particularly in women, according to a study presented at the annual American Stroke Association...
Source: Drugs.com - Pharma News - February 9, 2023 Category: Pharmaceuticals Source Type: news
ASA: Racial Differences Seen in Treatment of Common Poststroke Sequelae
MONDAY, Feb. 6, 2023 -- Considerable racial differences are seen in the treatment of common poststroke sequelae, according to a study presented at the American Stroke Association International Stroke Conference, held from Feb. 8 to 10 in...
Source: Drugs.com - Pharma News - February 6, 2023 Category: Pharmaceuticals Source Type: news
AMI, Stroke Risk Elevated for Women With Preeclampsia Within 20 Years
FRIDAY, Feb. 3, 2023 -- Women with a history of preeclampsia have a significantly increased risk for acute myocardial infarction (AMI) and ischemic stroke within and after 10 years of delivery, according to a study published online Jan. 26 in the...
Source: Drugs.com - Pharma News - February 3, 2023 Category: Pharmaceuticals Source Type: news
Cumulative Exposure to Estrogen Linked to Lower Risk for Stroke
THURSDAY, Feb. 2, 2023 -- Lifetime cumulative exposure to estrogen is associated with a reduced risk for stroke, according to a study published online Feb. 1 in Neurology.
Leying Hou, Ph.D., from Zhejiang University School of Medicine in Hangzhou,...
Source: Drugs.com - Pharma News - February 2, 2023 Category: Pharmaceuticals Source Type: news
